Tobrasone 5 Ml

説明

Tobrasone 5 ml Eye Drops (Tobramycin 0.3% & Fluorometholone 0.1% Ophthalmic Suspension) is a high-performance, dual-action therapeutic formulation manufactured by Alcon (a Novartis division). Specifically engineered for the treatment of steroid-responsive inflammatory ocular conditions where a bacterial infection is present or suspected, Tobrasone combines a broad-spectrum aminoglycoside antibiotic with a moderate-potency corticosteroid. This combination is particularly valued in clinical practice for its ability to provide intensive anti-inflammatory relief with a significantly lower risk of elevating intraocular pressure (IOP) compared to more potent steroid combinations.

1. Manufacturer Profile: Alcon (Novartis)

Alcon is a global leader in eye care innovation, recognized for its commitment to high-purity pharmaceutical formulations and advanced delivery systems.

• Quality Assurance: Produced in world-class facilities certified under WHO-GMP and US FDA standards, ensuring that every 5 ml unit of Tobrasone maintains precise molecular stability and sterility.
• Innovation: Alcon’s expertise in suspension technology ensures that the active ingredients in Tobrasone are uniformly distributed, providing a consistent therapeutic dose with every actuation.

2. Composition & Active Ingredients

Each 1 ml of Tobrasone contains a synergistic ratio of active agents:

• Tobramycin USP: 3 mg (0.3% w/v) – Bactericidal antibiotic.
• Fluorometholone USP: 1 mg (0.1% w/v) – Moderate-potency corticosteroid.
• Preservative: Benzalkonium Chloride 0.01% w/v (standard multi-dose stabilizer).
• Vehicle: Sterile aqueous suspension designed for optimal corneal adherence.

3. Mechanism of Action: How It Works

Tobrasone utilizes a two-pronged attack to eliminate bacterial pathogens and suppress the body’s inflammatory response.

A. Rapid Antibacterial Coverage (Tobramycin)

Tobramycin works by irreversibly binding to the 30S and 50S subunits of the bacterial ribosome. This action effectively halts the synthesis of essential proteins required for bacterial growth and replication. It is highly active against common ocular pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa.

B. Safe Anti-Inflammatory Control (Fluorometholone)

Fluorometholone is a “soft” steroid that inhibits the release of prostaglandins and other chemical mediators of inflammation. Its unique molecular structure allows it to be rapidly metabolized within the eye, which provides effective relief from redness and swelling while minimizing the risk of “steroid-induced” increases in eye pressure—a common complication with other corticosteroids like Dexamethasone.

4. Therapeutic Indications

Tobrasone 5 ml is clinically indicated for:

• Inflammatory Bacterial Conjunctivitis: Treating infections accompanied by significant ocular swelling and irritation.
• Post-Operative Management: Reducing inflammation and preventing infection after cataract, glaucoma, or refractive surgeries.
• Steroid-Responsive Ocular Surface Disease: Managing severe blepharitis and keratitis where bacterial involvement is suspected.
• Ocular Trauma: 二次的な角膜の小さな傷や化学やけど後の感染症予防。

5. 臨床比較：Tobrasone vs. TobraDex

6. 投与量と投与方法

標準投与プロトコル

• 成人および2歳以上の子供： 4～6時間ごとに影響を受けた目(目)に1～2滴点眼。
• 急性期： 最初の24～48時間、医師は炎症がコントロールされるまで2時間ごとに投与することができます。

投与ガイドライン

1. 手を十分に洗い、**よく振る**（懸濁液はよく混ぜる必要があります）。
2. 頭を後ろに傾け、下眼瞼を軽く引き下げる。
3. ドロッパーの先端が目やまつ毛に触れないように、1滴点眼する。
4. 目を閉じて1～2分間保ち、内側の隅に圧力をかける。
5. 接触レンズを再挿入する前に少なくとも15分待つ。

7. 注意事項と安全警告

• ウイルス/真菌感染症： ステロイドはヘルペス単純ウイルスなどのウイルス性眼疾患を悪化させることがあります。細菌感染が確認されていない限り使用しないでください。
• 長期使用： 医師の処方した期間だけ使用してください。長期間の使用（10日以上）は眼圧の臨床的モニタリングを必要とします。
• 無菌性： キャップをしっかり閉めます。開封後30日以内に残った懸濁液は廃棄してください。

8. よく研究されたFAQ

Q: TobrasoneはTobraDexより優れていますか？

A: 患者によります。重症の炎症にはTobraDexの方が強力です。ただし、眼圧上昇のリスクがある患者や長期のステロイド療法を必要とする患者にはTobrasoneが好まれます。

Q: Can I use Tobrasone for my child?

A: Yes, it is generally safe for children aged 2 years and older when used under the strict guidance of a pediatrician or ophthalmologist.

Q: Why is my vision blurry right after using the drops?

A: This is normal. Tobrasone is a suspension and may cause temporary blurring of vision for a few minutes after application. Do not drive until your vision clears.

9. Official Regulatory References

1. Alcon Product Index: Global Ophthalmic Portfolio
2. DailyMed NIH: Tobramycin and Fluorometholone Ophthalmic Monographs.

Medical Disclaimer: This content is AI-generated for educational purposes based on clinical pharmaceutical data. It is NOT medical advice. Always consult a licensed healthcare professional for diagnosis and treatment.